Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Crespo

Plastic and Reconstructive Surgery Orlando, FL Medical Doctor

NPI 1790123487 CMS profile 1182858

125 W Copeland Dr, Orlando, FL 32806

Open in the dashboard

General payments

$8,273

87 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Crespo of Orlando, FL is reported in the CMS Open Payments database as having received $8,273 across 87 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,496 26
2024 General $1,258 21
2023 General $1,335 20
2022 General $45 2
2021 General $78 4
2020 General $171 2
2019 General $1,891 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Crespo
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Jason Crespo were reported at $3,496. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Jason Crespo Plastic and Reconstructive Surgery median Middle half National median
2019 $1,891 $335 $121–$1,264 $163
2020 $171 $162 $57–$417 $114
2021 $78 $245 $89–$735 $132
2022 $45 $325 $120–$932 $149
2023 $1,335 $343 $129–$999 $160
2024 $1,258 $390 $141–$1,085 $164
2025 $3,496 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $2,112 7 payments
  2. Stryker Corporation $1,798 11 payments
  3. Medical Device Business Services, Inc. $916 11 payments
  4. Mentor Worldwide LLC $895 12 payments
  5. AbbVie, Inc. $631 11 payments
  6. Integra LifeSciences Corporation $444 7 payments
  7. Organogenesis Inc. $340 5 payments
  8. PolyNovo North America LLC $220 3 payments
  9. Medtronic USA, Inc. $150 1 payment
  10. Endo Pharmaceuticals Inc. $111 1 payment
  11. Other $656 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,610 76 payments
  2. Travel and Lodging $3,513 10 payments
  3. Consulting Fee $150 1 payment
Products named General payments · program years 2019–2025
  1. AXOGUARD Neurology $2,008 5 payments
  2. AXOGUARD Neurology $2,008 5 payments
  3. AXOGUARD HA+ NERVE PROTECTOR $2,008 5 payments
  4. AXOGUARD NERVE CAP $2,008 5 payments
  5. UNIVERSAL MID-FACE $1,745 9 payments
  6. MENTOR MemoryGel Resterilizable Gel Sizer $812 10 payments
  7. Integra Recon-Skin And Wound $444 7 payments
  8. Integra Recon-Skin And Wound $444 7 payments
  9. INTEGRA DERMAL REGENERATION TEMPLATE $444 7 payments
  10. NATRELLE SALINE-FILLED BREAST IMPLANTS $325 4 payments
  11. Other $3,751 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$18,796

Medicare's payments for the services billed

Medicare patients

24

Average age 65

Services billed

70

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 54%
Cancer 50%
Depression 50%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

87 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record